Carl L. Gordon
Sits on 9 boards. Overboarded · 9 public boards Last updated September 28, 2026
Time on boards
- Boards served
- 9
- Current seats
- 9
- Board service
- 17 years
- Director since
- 2023
17 years of board service in total across 9 boards, counting each seat separately. Longest: Compass Therapeutics Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Compass Therapeutics Inc. June 11, 202595.0%
-
Keros Therapeutics Inc. June 6, 202346.1%
-
Adicet Bio Inc. June 1, 202374.4%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 10, 2026 | Electra Therapeutics Inc. | Open-market purchase | +20,700 | $8.45 | $174,915 |
| Nov 10, 2026 | Electra Therapeutics Inc. | Open-market purchase | +2,000 | $8.45 | $16,900 |
| Nov 9, 2026 | Electra Therapeutics Inc. | Open-market purchase | +4,000 | $8.24 | $32,960 |
| Nov 9, 2026 | Electra Therapeutics Inc. | Open-market purchase | +16,000 | $8.24 | $131,840 |
| Nov 6, 2026 | Electra Therapeutics Inc. | Open-market purchase | +9,816 | $7.85 | $77,056 |
| Nov 6, 2026 | Electra Therapeutics Inc. | Open-market purchase | +39,600 | $7.85 | $310,860 |
| Nov 5, 2026 | Electra Therapeutics Inc. | Open-market purchase | +30,891 | $7.31 | $225,813 |
| Nov 5, 2026 | Electra Therapeutics Inc. | Open-market purchase | +125,200 | $7.31 | $915,212 |
| Nov 4, 2026 | Electra Therapeutics Inc. | Open-market purchase | +9,267 | $7.78 | $72,097 |
| Nov 4, 2026 | Electra Therapeutics Inc. | Open-market purchase | +37,100 | $7.78 | $288,638 |
| Nov 4, 2026 | Electra Therapeutics Inc. | Open-market purchase | +5,000 | $7.07 | $35,350 |
| Nov 4, 2026 | Electra Therapeutics Inc. | Open-market purchase | +20,000 | $7.07 | $141,400 |
| Nov 3, 2026 | Electra Therapeutics Inc. | Open-market purchase | +24,313 | $7.84 | $190,614 |
| Nov 3, 2026 | Electra Therapeutics Inc. | Open-market purchase | +97,800 | $7.84 | $766,752 |
| Nov 3, 2026 | Electra Therapeutics Inc. | Open-market purchase | +24,400 | $7.88 | $192,272 |
Questions about Carl L. Gordon
What boards is Carl L. Gordon on?
Carl L. Gordon sits on the boards of ADARx Pharmaceuticals Inc., Adicet Bio Inc., ArriVent BioPharma Inc., BlossomHill Therapeutics Inc., Compass Therapeutics Inc., Electra Therapeutics Inc., Keros Therapeutics Inc., MBX Biosciences Inc. and Scribe Therapeutics Inc.
How long has Carl L. Gordon served on boards?
Our records show at least 17 years of board service across 9 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.